NASDAQ Global Market • Healthcare • Biotechnology • US • USD
Magenta Therapeutics, Inc. (MGTA) has a market capitalization of $42.44M and trades at $0.70. The 52-week range is 0.321-1.81.
Key metrics include annual revenue of $2.04M.
The stock has a beta of 2.11, operates in the Healthcare sector.
Be the first to know when stocks drop below their intrinsic value.
